CA2356452A1 - Compositions et procedes pour reduire ou prevenir la fertilisation chez des poissons et des oiseaux - Google Patents

Compositions et procedes pour reduire ou prevenir la fertilisation chez des poissons et des oiseaux Download PDF

Info

Publication number
CA2356452A1
CA2356452A1 CA002356452A CA2356452A CA2356452A1 CA 2356452 A1 CA2356452 A1 CA 2356452A1 CA 002356452 A CA002356452 A CA 002356452A CA 2356452 A CA2356452 A CA 2356452A CA 2356452 A1 CA2356452 A1 CA 2356452A1
Authority
CA
Canada
Prior art keywords
vaccine composition
composition according
fish
ipvl
immunocontraceptive vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002356452A
Other languages
English (en)
Inventor
Robert Brown
Bill Pohajdak
Janet Horrocks
Leslie Maclaren
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dalhousie University
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2356452A1 publication Critical patent/CA2356452A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0006—Contraceptive vaccins; Vaccines against sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Reproductive Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Cette invention se rapporte à une composition de vaccin immunocontraceptif, qui comprend un homologue téléostéen de zona pellucida (TH-ZP), associé à un diluant ou excipient acceptable sur le plan pharmaceutique, en vue de réduire ou de prévenir la fertilisation chez un poisson, ainsi qu'à un procédé d'utilisation de cette composition. Cette invention se rapporte également à une composition de vaccin immunocontraceptif, qui comprend un antigène provenant d'une couche périvitelline interne (IPVL), associé à un diluant ou excipient acceptable sur le plan pharmaceutique, en vue de réduire ou de prévenir la fertilisation chez un oiseau, ainsi qu'à un procédé d'utilisation de cette composition.
CA002356452A 1998-12-22 1999-12-22 Compositions et procedes pour reduire ou prevenir la fertilisation chez des poissons et des oiseaux Abandoned CA2356452A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11352698P 1998-12-22 1998-12-22
US60/113,526 1998-12-22
PCT/CA1999/001225 WO2000037100A2 (fr) 1998-12-22 1999-12-22 Compositions et procedes pour reduire ou prevenir la fertilisation chez des poissons et des oiseaux

Publications (1)

Publication Number Publication Date
CA2356452A1 true CA2356452A1 (fr) 2000-06-29

Family

ID=22349942

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002356452A Abandoned CA2356452A1 (fr) 1998-12-22 1999-12-22 Compositions et procedes pour reduire ou prevenir la fertilisation chez des poissons et des oiseaux

Country Status (4)

Country Link
EP (1) EP1140151A2 (fr)
AU (1) AU1765300A (fr)
CA (1) CA2356452A1 (fr)
WO (1) WO2000037100A2 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2378472A1 (fr) * 1999-07-01 2001-01-11 The University Of Georgia Research Foundation, Inc. Procede et composition permettant d'affecter les systemes de reproduction
DE60117164T2 (de) 2000-11-07 2006-08-03 Immuno Vaccine Technologies Inc., Halifax Impfstoffe mit erhöhter immunantwort und verfahren zur deren herstellung
AU2003229199A1 (en) * 2002-05-31 2003-12-19 Alpharma As Liposome vaccine formulations for fin-fish
CA2523032A1 (fr) 2005-10-07 2007-04-07 Immunovaccine Technologies Inc. Vaccins pour la therapie du cancer
WO2009039628A1 (fr) 2007-09-27 2009-04-02 Immunovaccine Technologies Inc. Utilisation de liposomes dans un véhicule composant une phase hydrophobe continue pour la délivrance de polynucléotides in vivo
CA2723918C (fr) 2008-06-05 2018-01-09 Immunovaccine Technologies Inc. Compositions contenant des liposomes, un antigene, un polynucleotide et un transporteur comprenant une phase continue d'une substance hydrophobe
SG11201401177WA (en) 2011-10-06 2014-04-28 Immunovaccine Technologies Inc Liposome compositions comprising an adjuvant that activates or increases the activity of tlr2 and uses thereof
GB201204280D0 (en) 2012-03-09 2012-04-25 Univ Nordland Methods

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992009684A1 (fr) * 1990-11-21 1992-06-11 Washington University Vaccins anticonceptionnels de salmonella avirulent recombinant
GB9100468D0 (en) * 1991-01-09 1991-02-20 Proteus Molecular Design Improvements in and relating to hormones
WO1993025231A1 (fr) * 1992-06-05 1993-12-23 Dalhousie University Utilisation de glycoproteines de la zone pellucide dans l'immunocontraception

Also Published As

Publication number Publication date
EP1140151A2 (fr) 2001-10-10
WO2000037100A2 (fr) 2000-06-29
AU1765300A (en) 2000-07-12
WO2000037100A3 (fr) 2000-12-07

Similar Documents

Publication Publication Date Title
US9579379B1 (en) Saponin adjuvant compositions and methods relating thereto
KR20080005277A (ko) 씨. 퍼프린겐스 알파 톡소이드 백신
JP5231378B2 (ja) 免疫原性ｌｈｒｈ組成物およびそれに関する方法
US20200069781A1 (en) Immunogenic lhrh composition and use thereof in pigs
CA2356452A1 (fr) Compositions et procedes pour reduire ou prevenir la fertilisation chez des poissons et des oiseaux
EP0804219B1 (fr) Compositions a base d'inhibine et applications
US6790457B1 (en) Compositions and methods for reducing or preventing fertilization in fish and birds
US5955080A (en) Self-adjuvanting peptide vaccine delivery system and production thereof
HUT52787A (en) Process for production of biologically active peptides
WO2001002000A9 (fr) Procede et composition permettant d'affecter les systemes de reproduction
US8940693B2 (en) Protein for the immunocastration for mammals
WO2008110912A1 (fr) Régulation de fertilité chez des chevaux
CA2378478A1 (fr) Vaccin anti-fecondite contenant une proteine de membrane pellucide aviaire et procede d'utilisation
AU2001266197A1 (en) Contraceptive vaccines for pest control

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead